FDA approves generic glucagon for treating severe hypoglycemia ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS
You ve successfully added to your alerts. You will receive an email when new content is published.
Back to Healio
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
The FDA has approved the first generic glucagon for injection, commonly used to treat severe hypoglycemia in individuals with diabetes taking insulin, according to an agency press release.